The standard method for breast cancer classification uses immunohistochemistry (IHC) markers such as progesterone receptor (PR), human epidermal growth factor receptor II (HER2), and estrogen receptor (ER) together with Ki67 (5, 6). This evidence concerns the gene PGR and breast carcinoma.